The Impact of CDH13 Polymorphism and Statin Administration on TG/HDL Ratio in Cardiovascular Patients.

doi:10.3349/ymj.2015.56.6.1604

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The Impact of CDH13 Polymorphism and Statin Administration on TG/HDL Ratio in Cardiovascular Patients.

Yonsei medical journal - 1 Nov 2015

Choi Jung Ran, Jang Yangsoo, Kim Yoon Sungjoo, Park Jong Keun, Sorn Sungbin Richard, Park Mi-Young, Lee Myoungsook

Abstract excerpt

PURPOSE: Adiponectin is expressed in adipose tissue, and is affected by smoking, obesity, and genetic factors, such as CDH13 polymorphism, contributing to the development of coronary vascular diseases (CVDs). MATERIALS AND METHODS: We investigated the effect of genetic variations of CDH13 (rs3865188) on blood chemistry and adiponectin levels in 345 CVD patients undergoing statin-free or statin treatment. RESULTS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adiponectin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cadherins

Share to Cholesterol, LDL

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Interleukin-6

Share to Leptin

Share to Lipoproteins, HDL

Share to Vascular Diseases

Source

Open in PubMed Open full text

Identifiers

PMID: 26446643
DOI: 10.3349/ymj.2015.56.6.1604
PMCID: PMC4630049

Genes

CDH13
TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Impact of CDH13 Polymorphism and Statin Administration on TG/HDL Ratio in Cardiovascular Patients.PMID 26446643Read ↗

Association between CDH13 variants and cardiometabolic and vascular phenotypes in a Korean population.Semantic proximity Read ↗

Association of CDH13 genotypes/haplotypes with circulating adiponectin levels, metabolic syndrome, and related metabolic phenotypes: the role of the suppression effect.Semantic proximity Read ↗

Genome-Wide Association Study on Adiponectin-Mediated Suppression of HDL-C Levels in Taiwanese Individuals Identifies Functional Haplotypes in CDH13.Semantic proximity Read ↗

Effects of smoking and obesity on the association between CDH13 (rs3865188) and adiponectin among Korean men: the KARE study.Semantic proximity Read ↗

A variant upstream of the CDH13 adiponectin receptor gene and metabolic syndrome in Swedes.Semantic proximity Read ↗

CDH13 Polymorphisms are Associated with Adiponectin Levels and Metabolic Syndrome Traits Independently of Visceral Fat Mass.Semantic proximity Read ↗

CDH13 gene coding T-cadherin influences variations in plasma adiponectin levels in the Japanese population.Semantic proximity Read ↗

Differential Associations between CDH13 Genotypes, Adiponectin Levels, and Circulating Levels of Cellular Adhesive Molecules.Semantic proximity Read ↗

Adiponectin concentrations: a genome-wide association study.Semantic proximity Read ↗

Genetic variation in CDH13 is associated with lower plasma adiponectin levels but greater adiponectin sensitivity in East Asian populations.Semantic proximity Read ↗

Effect of Adiponectin Variant on Lipid Profile and Plasma Adiponectin Levels: A Multicenter Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Association Between CDH13 rs12596316 and Adiponectin Levels According to Fasting Glucose Status in a Korean Population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.